Onkoskrining

Main article: Cancer diagnosis

2021:85 percent of Russians have never passed oncoscreening in their lives

On January 31, 2022, Kirill Rodin presented data surveys VCIOM on awareness Russians to melanoma of and readiness to undergo examinations, as well as the results of screenings conducted in,, Novosibirsk Chelyabinsk Zlatoust and. Magnitogorsk

In 2021, free screenings were held for the detection of malignant neoplasms in 4 cities - Chelyabinsk, Zlatoust, Magnitogorsk and Novosibirsk. In total, 3,045 people were examined, malignant neoplasms were found in 26 cases, "said Alexander Kuzichev, acting head of the company's oncology business unit. BIOCAD- In 2022, examinations will continue, screenings will be held in 5 federal districts. Russia

The Live Without Fear program has been held for several years. During this time, a two-stage screening was formed, which consists of an examination of dermatologists and the intervention of oncologists. A large information company was previously held, which attracted the attention of a large number of people from the regions where it was held. But the main thing is that a large number of people, not only those who came for the inspection, but also those who would come later, thanks to publications, saw that this is a short, non-urgent and simple process and that specialized assistance is provided, despite the restrictions associated with the covid and pandemic, Igor Samoilenko said.

The expert also said that at the invitation of the government of the country, in 2021, 77 inspections of residents of the Republic of the Congo were carried out, 30 of them showed malignant skin neoplasms or suspicions of them. Also, as part of the program in the Congo, Russian specialists carried out more than 10 surgical operations. Developed educational materials for albinos on self-diagnostics and skin protection in French.

BIOCAD, as a developer and manufacturer of medicines with a full portfolio of antitumor drugs, constantly increases the availability of highly effective drugs, and also actively participates in educational and information programs aimed at early detection of diseases.